Influenza-like Illness Clinical Trials
2 recruiting trials for Influenza-like Illness. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Influenza-like Illness clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Fudan University (1), Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is No intervention involved (other, 1 trial), followed by Training Session on acute respiratory infection guideline within a multifaceted implementation strategy.
Track Influenza-like Illness trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Fever Clinic Acute Respiratory Cohort
This prospective cohort study aims to characterize the natural progression and outcomes of acute respiratory infections among patients presenting to fever clinics. At enrollment,...
Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic...
The ImpProGUIDE study aims to find out whether implementing new Swiss national guidelines for acute respiratory infections (ARI) can help to reduce antibiotic prescribing in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Influenza-like Illness, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Influenza-like Illness, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Influenza-like Illness, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.